Physician profile
Eric Slavin Bronfenbrenner
NPI 1427498773
$7,793.21
in general payments reported to CMS, 2019-2025
11 companies · $364 in 2025
The $364 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,044 · 2020: $545 · 2021: $201 · 2022: $2,304 · 2023: $434 · 2024: $1,901 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,373 · Travel and Lodging: $1,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,372.67 |
| Travel and Lodging | $1,325.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,713.15 | 2019-2025 | Prostep, Augment Injectable, Infinity Adaptis |
| Arthrex, INC. | $1,509.22 | 2020-2022 | |
| Novus Surgical Consultants | $729.85 | 2022-2025 | |
| Novus Surgical Solutions LLC | $345.63 | 2021-2022 | |
| Treace Medical Concepts, INC. | $133.20 | 2023-2024 | |
| Pacira Pharmaceuticals Incorporated | $124.80 | 2019 | |
| Zimmer Biomet Holdings, INC. | $105.82 | 2020 | |
| Smith+Nephew, INC. | $50.21 | 2022-2025 | Stravix Pl, Grafix Pl, Oasis |
| Wright Medical Technology, INC. | $36.01 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $30.05 | 2023 | Jublia, Arazlo |
| Integra Lifesciences Corporation | $15.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Bronfenbrenner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.